CN101385796B - 一种制剂在制备改善因老化致认知功能障碍和老年痴呆药物中的应用 - Google Patents
一种制剂在制备改善因老化致认知功能障碍和老年痴呆药物中的应用 Download PDFInfo
- Publication number
- CN101385796B CN101385796B CN2007101460568A CN200710146056A CN101385796B CN 101385796 B CN101385796 B CN 101385796B CN 2007101460568 A CN2007101460568 A CN 2007101460568A CN 200710146056 A CN200710146056 A CN 200710146056A CN 101385796 B CN101385796 B CN 101385796B
- Authority
- CN
- China
- Prior art keywords
- qingkailing
- group
- preparation
- brain
- senile dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
试验类型 | 时间 | 对照组 N=15 | SAMP8模型组 N=15 | 清开灵组 N=15 | 精制清开灵组 N=15 | 西药安理申组 N=15 |
隐蔽平台试验 反向试验 可视平台试验 | Day1 Day2 Day3 Day4 Day5 Day7 Day8 Day9 Day10 | 54.71±4.48 33.59±5.42 33.34±14.52** 30.39±15.17** 42.87±10.89** 50.54±11.37 40.66±14.51* 30.34±18.99** 29.67±5.23 | 59.12±1.80 56.32±4.17 55.31±1.62 58.67±0.89 58.45±0.53 59.74±0.38 59.56±0.54 57.70±1.28 35.16±10.35 | 57.70±6.07 47.81±11.92 46.53±10.26* 43.53±10.18* 42.87±10.89** 56.01±4.60 39.89±9.73* 35.81±8.84* 35.06±12.41 | 59.59±1.25 53.92±10.06 48.98±15.14* 45.57±12.90* 47.95±12.73* 54.03±11.55 42.83±14.32* 38.30±9.84* 34.78±10.96 | 55.87±8.89 47.69±17.92 46.74±16.60* 48.80±15.68* 44.87±17.26* 57.78±4.91 48.14±8.64 42.34±6.82 34.91±8.30 |
组别 | n | 持续时间 | 路径长度 |
假手术组模型组安理申治疗组精制清开灵组清开灵组 | 10 10 10 10 10 | 9.3±5.1 23.5±9.1# 17.3±5.6 10.6±10.0* 9.3±3.6* | 268.9±186.9 696.3±227.3## 436.7±284.4* 335.7±103.6* 321.1±112.1* |
组别 | N | AD Mean | OD Mean |
对照组模型组安理申治疗组精制清开灵组清开灵组 | 10 10 10 10 10 | 10.90±2.27* 15.71±3.19 13.32±2.39 11.84±1.84* 11.14±1.68* | 109.80±14.41** 143.03±14.78 130.39±25.29 107.33±19.83* 117.33±19.83* |
组别 | N | AD Mean | OD Mean |
对照组模型组安理申治疗组精制清开灵组清开灵组 | 10 10 10 10 10 | 12.11±2.92* 18.57±5.64 12.34±3.87* 13.08±4.77* 12.46±2.55* | 115.55±13.44** 143.66±8.15 118.6±18.91* 121.34±13.04* 111.34±13.04* |
组别 | N | AD Mean | OD Mean |
对照组模型组安理申治疗组精制清开灵组清开灵组 | 10 10 10 10 10 | 9.89±2.67** 4.54±0.87 8.32±3.39* 8.12±2.49* 8.70±2.29** | 115.30±8.84** 73.34±5.59 98.08±9.30* 99.08±8.50* 112.34±16.45** |
组别 | N | AD Mean | OD Mean |
对照组模型组精制清开灵组安理申治疗组清开灵组 | 10 10 10 10 10 | 18.77±5.88** 9.28±1.85 16.84±6.47** 15.94±5.37** 17.44±3.22** | 85.68±16.58** 56.30±13.00 71.47±9.68** 87.47±12.86** 77.86±11.97** |
组别 | n | ACh含量(μg/L) |
假手术组模型组安理申治疗组组精制清开灵组清开灵组 | 6 6 6 6 6 | 212.8±41.7 165.7±18.5## 179.0±33.5 217.8±44.1* 255.4±35.4** |
组别 | n | NE | DOPAC | DA | 5-HIAA | HVA | 5-HT |
假手术组模型组安理申治疗组清开灵组精制清开灵治疗组 | 6 6 6 6 6 | 108.7±16.5 69.6±19.5 75.9±11.3 105.6±5.8 112.2±12.5 | 18.2±3.6 10.7±2.0 13.4±1.3 12.6±2.0 14.1±2.4 | 168.4±36.5 118.4±14.2 136.2±8.5 177.3±12.9 165.7±15.6 | 48.7±11.4 25.6±13.2# 27.3±3.1 49.3±6.2 47.4±3.6 | 18.3±3.3 13.5±4.2 15.4±9.4 9.4±1.5* 8.1±4.6* | 58.3±9.0 42.6±7.6# 41.7±5.9 59.9±8.4 42.7±8.8 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101460568A CN101385796B (zh) | 2007-09-10 | 2007-09-10 | 一种制剂在制备改善因老化致认知功能障碍和老年痴呆药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101460568A CN101385796B (zh) | 2007-09-10 | 2007-09-10 | 一种制剂在制备改善因老化致认知功能障碍和老年痴呆药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101385796A CN101385796A (zh) | 2009-03-18 |
CN101385796B true CN101385796B (zh) | 2012-05-23 |
Family
ID=40475602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101460568A Expired - Fee Related CN101385796B (zh) | 2007-09-10 | 2007-09-10 | 一种制剂在制备改善因老化致认知功能障碍和老年痴呆药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101385796B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103191142B (zh) * | 2013-03-15 | 2018-11-06 | 江西青峰药业有限公司 | 黄芩苷和牛磺酸组合物及其制备药物用途 |
CN111840390B (zh) * | 2020-09-01 | 2023-03-24 | 北京中医药大学 | 改善认知功能障碍的药物组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1602893A (zh) * | 2004-08-06 | 2005-04-06 | 北京中医药大学 | 一种治疗脑中风的药物组合物及其制备方法 |
-
2007
- 2007-09-10 CN CN2007101460568A patent/CN101385796B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1602893A (zh) * | 2004-08-06 | 2005-04-06 | 北京中医药大学 | 一种治疗脑中风的药物组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
张占军等.清开灵组分配伍干预局灶性脑缺血大鼠再灌注损伤的实验研究.《中国药理学通报》.2006,第22卷(第8期),964-967. * |
朱玲.清开灵注射液临床新用举隅.《实用中医药杂志》.1996,(第1期),31. * |
Also Published As
Publication number | Publication date |
---|---|
CN101385796A (zh) | 2009-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102548571B (zh) | 用于预防和治疗脑部疾病和疾病状态的组合物和方法 | |
Choi et al. | Cistanches Herba enhances learning and memory by inducing nerve growth factor | |
CN107427502A (zh) | 使用川地匹坦的治疗方法 | |
CN102160852A (zh) | 一种布洛芬注射液及制备方法 | |
Li et al. | Microglia TREM2: A potential role in the mechanism of action of electroacupuncture in an Alzheimer’s disease animal model | |
Zhang et al. | Lesion of medullary catecholaminergic neurons is associated with cardiovascular dysfunction in rotenone‐induced Parkinson's disease rats | |
CN101385796B (zh) | 一种制剂在制备改善因老化致认知功能障碍和老年痴呆药物中的应用 | |
Wang et al. | Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss | |
CN101904838A (zh) | 藁本内酯在制备防治老年痴呆病症组合物中的应用 | |
Jiang et al. | Mitochondrial-derived peptide MOTS-c ameliorates spared nerve injury-induced neuropathic pain in mice by inhibiting microglia activation and neuronal oxidative damage in the spinal cord via the AMPK pathway | |
CN102091105B (zh) | 败酱草及其制剂的新用途 | |
Hüttenrauch et al. | Connecting mind-body therapy-mediated effects to pathological features of Alzheimer’s disease | |
CN102000148B (zh) | 黄芩及黄芩苷在制备改善学习记忆及治疗老年性痴呆药物中的应用 | |
CN102018747B (zh) | 红芪和红芪多糖在制备改善学习记忆及治疗阿尔茨海默病药物的应用 | |
Yang et al. | α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil | |
CN113143985A (zh) | 一种雷公藤提取成分脂质体在制备鼻腔给药防治脂多糖诱导的行为认知障碍药物中的应用 | |
Xie et al. | Effects of Shenqi Neijin powder on activation and apoptosis of hepatic stellate cells in rats with hepatic fibrosis | |
CN104739760B (zh) | 一种治疗脑水肿的药物组合物及其制剂 | |
RU2804398C1 (ru) | Применение производного бензопирана для лечения деменций альцгеймеровского типа, связанных с нарушением кальциевой регуляции | |
Muscat | Post-Operative Neurocognitive Disorder: Potentiating Factors and the Role of Toll-Like Receptor 4 | |
CN102526335B (zh) | 一种治疗痛风的外用中药 | |
Yuanshan et al. | Compound Chaijin Jieyu Tablets ameliorating insomnia complicated with depression by improving synaptic plasticity via regulating orexin A, melatonin, and acetylcholine contents | |
CN106619602A (zh) | 益母草碱的新用途 | |
CN110179984B (zh) | 增加腹侧海马到内侧前额叶皮质层铁转运的药物在制备治疗神经精神疾病药物中的应用 | |
CN104248750B (zh) | Fww三肽在制备治疗阿尔茨海默症药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LIU KECHENG Owner name: BEIJING NORMAL UNIVERSITY Free format text: FORMER OWNER: ZHANG ZHANJUN Effective date: 20100517 |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100517 Address after: 100875 Beijing city Haidian District Beijing Normal University Research Institute of cognitive neuroscience and learning Yingdong education building room 230 Applicant after: Beijing Normal University Address before: 100875 Beijing city Haidian District Beijing Normal University Research Institute of cognitive neuroscience and learning Yingdong education building room 230 Applicant before: Zhang Zhanjun Co-applicant before: Liu Kecheng |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhanjun Inventor after: The inventor has waived the right to be mentioned Inventor after: Wang Zhong Inventor after: Li Peng Inventor after: Liu Kecheng Inventor after: Li Pengtao Inventor after: Zhang Wensheng Inventor before: Wang Yongyan Inventor before: Wang Zhong Inventor before: Zhang Zhanjun Inventor before: Li Peng Inventor before: Liu Kecheng Inventor before: Li Pengtao Inventor before: Zhang Wensheng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG YONGYAN WANG ZHONG ZHANG ZHANJUN LI PENG LIU KECHENG LI PENGTAO ZHANGWENSHENG TO: ZHANG ZHANJUN REQUEST NOT TO RELEASE THE NAME WANG ZHONG LI PENG LIU KECHENG LI PENGTAO ZHANG WENSHENG |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20130910 |